2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1927
7Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1927
3Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepa- titis B virus-related hepatocellular carcinoma development u-sing liver stiffness measurement ( FibroScan ) [ J ]. Hepatology, 2011, 53 (3) : 885-894.
4Nishikawa H, Arimoto A, Wakasa T, et al. Pre-treatment C-reactive protein as a prognostic factor for recurrence after surgical resection of hepatocellular carcinoma [ J ]. Anticancer Res, 2013, 33(3) : 1181-1188.
5Kim do Y, Kim SU, Ahn SH, et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B[J]. Dig Dis Sci, 2009, 54(8) : 1758-1763.
6Cabrera R, Fitian AI, Ararat M, et al. Serum levels of solu- ble CD25 as a marker for hepatocellular carcinoma [ J ]. Oncol Lett, 2012, 4(4) : 840-846.
8Vergniol J, de L6dinghen V. Transient elastography (Fi- broScan) : a new tool in hepatology[ J]. Presse Med, 2009, 38(10) : 1516-1525.
9Imai N, Kinoshita A, Onoda H, et al. Persistent elevated C- reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma[ J ]. Clin Transl Oncol, 2013, 15(7) : 575-581.
10Komoriya T, Inoue N, Yoshimune K, et al. Use of a highly sensitive latex reagent with amino acid spacer for determina- tion of C-reactive protein concentration in a variety of liver diseases[J]. J Biosci Bioeng, 2012, 114(5): 560-563.
